These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9230532)

  • 1. Shigella vaccine research and development.
    Can Commun Dis Rep; 1997 Apr; 23(8):59-62. PubMed ID: 9230532
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful field trials with oral killed Shigella sonnei vaccine.
    Grahneis H
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
    [No Abstract]   [Full Text] [Related]  

  • 3. Live-attenuated Shigella vaccines.
    Venkatesan MM; Ranallo RT
    Expert Rev Vaccines; 2006 Oct; 5(5):669-86. PubMed ID: 17181440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprophylaxis against bacillary dysentery by dysentery live vaccine Vadizen (Shigella flexneri T32-Istrati) in children collectivities in SV County.
    Bogus L; Ianopol L; Dascălu C; Bende B; Iliescu C; Carliuc V; Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):291-8. PubMed ID: 6400302
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine research and development. New strategies for accelerating Shigella vaccine development.
    Wkly Epidemiol Rec; 1997 Mar; 72(11):73-9. PubMed ID: 9115858
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 8. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL; Tinge SA; Killeen KP; Kochi SK
    Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in PH County.
    Cuteanu I; Malamen G; Vlad A; Meitert T; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):313-21. PubMed ID: 6400305
    [No Abstract]   [Full Text] [Related]  

  • 13. Economical evaluation of the dysentery vaccination in B Municipality.
    Pănoiu L; Ion-Nedelcu N
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):337-40. PubMed ID: 6400308
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations concerning the immunoprophylactic effect of the antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children.
    Dragomir I; Iancu V; Călţun M; Raicu M; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):323-9. PubMed ID: 6400306
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities.
    Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):357-69. PubMed ID: 6763515
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation of a live Shigella vaccine using T32 strain (Roumania) in a form of popsicle and observation of its prophylactic efficacy].
    Zhao B
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):230-2. PubMed ID: 6640637
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic principles of activity and stability of attenuated live dysentery vaccines].
    Stenzel W
    Arzneimittelforschung; 1970 Oct; 20(10):1504-7. PubMed ID: 4921170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of the protective activity of ribosomal Sonne vaccine in monkeys].
    Levenson VI; Dzhikidze EK; Stasilevich ZK; Kavtaradze KN; Subbotina IuL
    Vestn Akad Med Nauk SSSR; 1986; (3):69-72. PubMed ID: 3518271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary studies on preparation of dysenteric vaccines with a bacillary polysaccharide-protein complex and its use in human immunization].
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Oct; 3(5):281-5. PubMed ID: 7185470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.